Page last updated: 2024-11-06

pro-diazepam

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pro-diazepam: diazepam prodrug [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71968
CHEMBL ID2103985
CHEBI ID2940
SCHEMBL ID34243
MeSH IDM0179463

Synonyms (26)

Synonym
65617-86-9
avizafone
avizafona [inn-spanish]
2'-benzoyl-4'-chloro-2-((s)-2,6-diaminohexanamido)-n-methylacetanilide
ro 03-7355/000
avizafonum [inn-latin]
pro-diazepam
(2s)-2,6-diamino-n-[2-(2-benzoyl-4-chloro-n-methylanilino)-2-oxoethyl]hexanamide
CHEMBL2103985
ro-037355000
chebi:2940 ,
65nk71k78p ,
avizafonum
unii-65nk71k78p
avizafone [inn:ban]
avizafona
avizafone [inn]
ro-03-7355/000
avizafone [who-dd]
avizafone [mart.]
SCHEMBL34243
(2s)-2,6-diamino-n-[2-(2-benzoyl-4-chloro-n-methyl-anilino)-2-oxo-ethyl]hexanamide
DTXSID90215868
Q4829057
(s)-2,6-diamino-n-(2-((2-benzoyl-4-chlorophenyl)(methyl)amino)-2-oxoethyl)hexanamide
AKOS040746599

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"), MB327 DMS reached plasma Cmax of 22μM at 12min with an elimination t1/2 of 22min."( Pharmacokinetic profile and quantitation of protection against soman poisoning by the antinicotinic compound MB327 in the guinea-pig.
Bird, M; Docx, CJ; Fairhall, SJ; Flint, DP; Green, AC; Poole, SJC; Price, ME; Rice, H; Tattersall, JEH; Timperley, CM; Whiley, L, 2016
)
0.43

Compound-Compound Interactions

ExcerptReferenceRelevance
" Here we have studied the pharmacokinetics of pralidoxime after its intramuscular injection alone or in combination with avizafone and atropine using an auto-injector device."( Pharmacokinetic analysis of pralidoxime after its intramuscular injection alone or in combination with atropine-avizafone in healthy volunteers.
Abbara, C; Bardot, I; Diquet, B; Ferec, S; Lallement, G; Lelièvre, B; Rousseau, JM; Turcant, A, 2010
)
0.36
"The injection of pralidoxime combination with atropine and avizafone provided a higher pralidoxime maximal concentration than that obtained after the injection of pralidoxime alone (out of bioequivalence range), while pralidoxime AUC values were equivalent."( Pharmacokinetic analysis of pralidoxime after its intramuscular injection alone or in combination with atropine-avizafone in healthy volunteers.
Abbara, C; Bardot, I; Diquet, B; Ferec, S; Lallement, G; Lelièvre, B; Rousseau, JM; Turcant, A, 2010
)
0.36

Bioavailability

ExcerptReferenceRelevance
"The aim of this study was to assess the relative bioavailability of diazepam after administration of diazepam itself or as a water-soluble prodrug, avizafone, in humans."( Bioavailability of diazepam after intramuscular injection of its water-soluble prodrug alone or with atropine-pralidoxime in healthy volunteers.
Abbara, C; Bardot, I; Clair, P; Comets, E; Diquet, B; Lallement, G; Rousseau, JM; Turcant, A, 2009
)
0.35
" The MDZ-pro/A oryzae protease system showed greater than 25-fold increase in absorption rate of MDZ across MDCKII-wt monolayers, compared to saturated MDZ."( Chirally Pure Prodrugs and Their Converting Enzymes Lead to High Supersaturation and Rapid Transcellular Permeation of Benzodiazepines.
Cheryala, N; Cloyd, JC; Georg, GI; Kapoor, M; Rautiola, D; Siegel, RA, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
peptideAmide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (16.67)18.2507
2000's8 (44.44)29.6817
2010's6 (33.33)24.3611
2020's1 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.28 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (11.11%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]